KRAS and colorectal carcinoma: The occurrence of KRAS, BRAF, IDH1, IDH2, PDGFRA, and TP53 mutations following whole genome sequencing testing of cfDNA was found to be a more popular etiologic biomarker for genomic instability in CRC, influencing about 75%–85% of cancers.